Physician profile
Jennifer E Collins
NPI 1568711794
$532.40
in general payments reported to CMS, 2019-2025
9 companies · $70.97 in 2025
The $70.97 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $160 · 2022: $12.95 · 2023: $199 · 2024: $89.64 · 2025: $70.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $359.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $125.14 | 2021 | |
| Alkermes, INC. | $102.10 | 2021-2024 | Aristada, Lybalvi |
| Ethicon INC. | $81.97 | 2023 | Monarch Platform |
| Abbvie INC. | $72.95 | 2023 | |
| Janssen Pharmaceuticals, INC | $61.39 | 2024-2025 | Invega Sustenna, Spravato |
| Novo Nordisk INC | $31.63 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $20.06 | 2025 | Gardasil 9, Capvaxive |
| Shield Therapeutics INC | $19.27 | 2024 | |
| Galderma Laboratories, L.P. | $17.89 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.